Quantcast
Channel: New-York – EEI-BIOTECHFINANCES
Viewing all articles
Browse latest Browse all 1030

Murdo Gordon Appointed Executive Vice President and Chief Commercial Officer

$
0
0
Monday, June 20th 2016 at 8:15pm UTC

NEW YORK–(BUSINESS WIRE)– Bristol-Myers
Squibb Company
(NYSE:BMY) today announced that Murdo
Gordon
has been appointed executive vice president and chief
commercial officer, a newly created position, effective June 21, 2016.
Gordon will be responsible for leading the execution of commercial
strategy across geographies. In this role, he will lead our Worldwide
Markets in addition to a new Worldwide Commercialization team. Gordon
will continue to report to Giovanni
Caforio
, M.D., chief executive officer, and remain a member of his
Leadership Team. Gordon most recently co-led the commercial organization
as Head of Worldwide Markets.

“Murdo has demonstrated tremendous success driving commercial excellence
at Bristol-Myers Squibb, and built strong relationships with our markets
across the world,” said Caforio. “Murdo has made significant
contributions to our success in Immuno-Oncology and Eliquis, and
I am confident his leadership will help drive continued growth and
deliver our medicines to more patients faster.”

Gordon joined Bristol-Myers Squibb in 1989 and spent the first 14 years
at the company in Canada where he held positions of increasing
responsibility in sales and marketing. Gordon moved into the company’s
U.S. operations in 2003 where he held senior commercial leadership
positions in cardiovascular, neuroscience and market access. He led
strategy and commercial operations as senior vice president for U.S.
Oncology and Immunoscience from 2011 to 2013, and served as president,
U.S. from 2013 to 2015. Murdo is a member of the Board of Directors of
RWJBarnabas Health and received a BSc in Cell and Molecular Biology from
Concordia University, Montreal, and also attended the General Management
Program, CEDEP at INSEAD, Fontainebleau, France.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission
is to discover, develop and deliver innovative medicines that help
patients prevail over serious diseases. For more information about
Bristol-Myers Squibb, visit us at BMS.com or
follow us on LinkedInTwitter,
YouTube
and Facebook.

Contacts

Bristol-Myers Squibb
Media:
Ken Dominski, 609-252-5251
ken.dominski@bms.com
or
Investors:
Bill
Szablewski, 609-252-5894
william.szablewski@bms.com

Source: Bristol-Myers Squibb Company

Cet article Murdo Gordon Appointed Executive Vice President and Chief Commercial
Officer
est apparu en premier sur EEI-BIOTECHFINANCES.


Viewing all articles
Browse latest Browse all 1030

Trending Articles